Page last updated: 2024-12-04

cannabinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cannabinol (CBN) is a non-psychoactive cannabinoid found in the cannabis plant. It is produced through the degradation of tetrahydrocannabinol (THC) by oxidation and heat. CBN is believed to have sedative and anti-inflammatory properties. It is studied for its potential therapeutic benefits in conditions such as insomnia, pain, and anxiety. CBN is also being investigated for its possible role in promoting bone growth.'
```

Cannabinol: A physiologically inactive constituent of Cannabis sativa L. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CannabisgenusThe plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.[MeSH]CannabaceaeA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.[MeSH]
Cannabis sativaspecies[no description available]CannabaceaeA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.[MeSH]

Cross-References

ID SourceID
PubMed CID2543
CHEMBL ID74415
CHEBI ID3360
SCHEMBL ID121085
MeSH IDM0003268

Synonyms (66)

Synonym
CHEMBL74415 ,
chebi:3360 ,
7uyp6mc9gh ,
unii-7uyp6mc9gh
cannabinolo
cannabinolum
5-17-04-00567 (beilstein handbook reference)
gtpl740
nsc-134455
6,9-trimethyl-3-pentyl-6h-dibenzo[b,d]pyran-1-ol
6h-dibenzo[b, 6,6,9-trimethyl-3-pentyl-
wln: t b666 ho ihj cq e5 i1 i1 m1
nsc134455
3-amyl-1-hydroxy-6,9-trimethyl-6h-dibenzo[b,d]pyran
3-amyl-1-hydroxy-6,6,9-trimethyl-6h-dibenzo(b,d)pyran
KBIO1_000972
DIVK1C_000972
cannabinol [inn:ban]
6,6,9-trimethyl-3-pentyl-6h-dibenzo(b,d)pyran-1-ol
nsc 134455
brn 0237145
IDI1_000972
cannabinol (6ci)
6h-dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl- (7ci,8ci,9ci)
cannabinolo [dcit]
6,6,9-trimethyl-3-pentyl-6h-dibenzo[b,d]pyran-1-ol
6h-dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
cannabinolum [inn-latin]
3-amyl-1-hydroxy-6,6,9-trimethyl-6h-dibenzo[b,d]pyran
6h-dibenzo(b,d)pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
cannabinol
521-35-7
C07580
NINDS_000972
NCGC00168261-01
LMPK13120002
L000158
HMS503C05
6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol(cannabinol)
6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol
6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol (cannabinol)
bdbm50061117
6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol
cas-521-35-7
dtxcid3028922
tox21_113486
dtxsid3048996 ,
cannabinol [mi]
cannabinol [who-dd]
cannabinol [inn]
SCHEMBL121085
6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol #
AKOS024457448
cannabinol, analytical standard
cannabinol 1.0 mg/ml in methanol
cannabinol; 3-amyl-1-hydroxy-6,6,9-trimethyl-6h-dibenzo[b,d]pyran; 6,6,9-trimethyl-3-pentyl-6h-dibenzo[b,d]pyran-1-ol; cbn; nsc 134455; cannabinoids
cannabinol (cbn)
DB14737
Q265831
cannabinol (cbn) 1000 microg/ml in methanol
cannabinol (cbn) 100 microg/ml in methanol
A934070
cannabinol (cbn) 250 microg/ml in acetonitrile
EN300-7456337
Z2680631269
cannabinol, 1mg/ml in methanol

Research Excerpts

Overview

Cannabinol (CBN) is an important degradation product of the predominant phytocannabinoids found in Cannabis species.

ExcerptReferenceRelevance
"Cannabinol (CBN) is an important degradation product of the predominant phytocannabinoids found in Cannabis species."( Identification and quantification of cannabinol as a biomarker for local hemp retting in an ancient sedimentary record by HPTLC-ESI-MS.
Csuk, R; Demske, D; Kluge, R; Kramell, AE; Oehler, F; Schmidt, T; Tarasov, PE, 2020
)
1.55

Treatment

ExcerptReferenceRelevance
"Cannabinol treatment had no effect on this parameter, but reduced body weight (P less than 0.02) in female fetuses, and increased ano-genital distance (P less than 0.05) in male fetal mice."( Fetal testosterone in mice: effect of gestational age and cannabinoid exposure.
Bartke, A; Dalterio, S, 1981
)
0.98

Toxicity

ExcerptReferenceRelevance
" As cannabigerol lacked these toxicities, it appears that the ocular hypotensive effect of this cannabinoid is somewhat dissociable from both the adverse central and ocular effects accompanying marihuana intake."( Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.
Allara, RD; Colasanti, BK; Craig, CR, 1984
)
0.49

Pharmacokinetics

ExcerptReferenceRelevance
" A drug's pharmacokinetics determines the onset, magnitude, and duration of its pharmacodynamic effects."( Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.
Huestis, MA, 2005
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
"A headspace solid-phase microextraction combined with GC-MS method was developed for the extraction and analysis of cannabinoids from Cannabis samples."( Extraction and analysis of different Cannabis samples by headspace solid-phase microextraction combined with gas chromatography-mass spectrometry.
Christen, P; Ilias, Y; Mathieu, P; Rudaz, S; Veuthey, JL, 2005
)
0.33
"The legalization of cannabis in many parts of the United States and other countries has led to a need for a more comprehensive understanding of cannabis constituents and their potential for drug-drug interactions."( Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Lazarus, P; Nasrin, S; Perez-Paramo, YX; Watson, CJW, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

The effects of delta-9-tetrahydrocannabinol (THC), cannabinol (CBN) and cannabidiol (CBD) on gonadotropin and testosterone (T) secretion and on hypothalamic norepinephrine (NE) metabolism were tested in adult male rats.

ExcerptRelevanceReference
" Neither multiple preimmunization dosings nor a single postimmunization dosing was effective."( Alterations in murine delayed type hypersensitivity responses by delta-8-THC and cannabinol.
Heppner, GH; Levy, JA,
)
0.36
"Recent advances in development of immunoassay methods for marijuana constituents in body fluids provide a rapid means of detection for forensic purposes and a useful research tool for accurate quantitation of dose-response relation."( Cannabis, 1977.
, 1978
)
0.26
"The acute dose-response effects of delta-9-tetrahydrocannabinol (THC), cannabinol (CBN) and cannabidiol (CBD) on gonadotropin and testosterone (T) secretion and on hypothalamic norepinephrine (NE) metabolism were tested in adult male rats."( Effects of psychoactive and nonpsychoactive cannabinoids on the hypothalamic-pituitary axis of the adult male rat.
Bartke, A; Murphy, LL; Smith, MS; Steger, RW, 1990
)
0.53
" Cannabinol (CBN) showed the same activity but required a dosage of approximately eight times that of THC to produce an equivalent effect."( The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.
Chesher, GB; Jackson, DM, 1985
)
1.43
"A Langendorff perfused rat heart preparation was designed to process dose-response effects of cardioactive drugs on rate, coronary flow, and supraaortic differential pressure (delta P; an index of cardiac performance)."( Effects and interactions of natural cannabinoids on the isolated heart.
Nahas, G; Trouve, R, 1985
)
0.27
" Oral fluid was tested prior to and immediately after dosing with either Sativex(®) or placebo at intervals up to 2h after the dose."( The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Allsop, DJ; Copeland, J; Fu, S; Lewis, J; Molnar, A, 2014
)
0.4
" After determination of control dose-response functions, mice received 10 mg/kg daily of THC for 7 days, and dose-response functions were re-determined 24 hours, 7 days, or 14 days later."( Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.
Chopda, GR; Gatley, SJ; Makriyannis, A; Parge, V; Paronis, CA; Thakur, GA, 2016
)
0.43
"6 mg Δ9-tetrahydrocannabinol (THC) in a randomized, placebo-controlled, within-subject dosing design."( Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Abulseoud, OA; Andersson, M; Barnes, AJ; Blount, BC; Huestis, MA; Newmeyer, MN; Schroeder, J; Sempio, C; Smith, ML, 2020
)
0.89
"We demonstrate that commercial CBD products, especially aqueous beverages, can show inconsistent labeling, vary largely from their label claims should they make them, and show lot-to-lot variability making dosing unpredictable."( Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Elder, EJ; Gidal, BE; Jones, KJ; Miller, OS, 2022
)
0.72
" Further preclinical and clinical investigations are warranted to elucidate their mechanisms of action, determine optimal dosage regimens, and assess long-term safety profiles."( Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review.
Kowalczuk, D; Kwiecień, E, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dibenzopyranAny organic heteropolycyclic compound based on a skeleton consisting of a pyran ring fused with two benzene rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (35)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency13.11500.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency25.86190.000221.22318,912.5098AID743035; AID743036; AID743042; AID743053; AID743054; AID743063
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency13.68680.000214.376460.0339AID720691; AID720692; AID720719
estrogen nuclear receptor alphaHomo sapiens (human)Potency26.38370.000229.305416,493.5996AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency22.21250.001019.414170.9645AID743094; AID743140
aryl hydrocarbon receptorHomo sapiens (human)Potency4.76890.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency13.33320.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency12.16930.000323.4451159.6830AID743065; AID743067
Cellular tumor antigen p53Homo sapiens (human)Potency21.59130.002319.595674.0614AID651631; AID720552
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency18.83360.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency18.83360.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)IC50 (µMol)0.30500.05102.47257.5000AID1845627; AID1845628
Cytochrome P450 2A6Homo sapiens (human)IC50 (µMol)30.40000.00443.889510.0000AID1845656
Cytochrome P450 2A6Homo sapiens (human)Ki1.00000.00561.52717.5000AID1845657
Cannabinoid receptor 1Rattus norvegicus (Norway rat)Ki0.21120.00020.566510.0000AID49495
Cytochrome P450 2B6Homo sapiens (human)Ki20.77500.00041.416010.0000AID1845658; AID1845659
Cannabinoid receptor 1Homo sapiens (human)Ki0.37280.00010.50779.6000AID1625146; AID1845649; AID1845650; AID49315
Cannabinoid receptor 2 Homo sapiens (human)Ki0.12170.00000.415610.0000AID1625147; AID1845651; AID1845652; AID49838; AID49846
Cannabinoid receptor 2Mus musculus (house mouse)Ki0.09600.00020.07970.7943AID49846
Cytochrome P450 2J2Homo sapiens (human)IC50 (µMol)19.00000.01202.53129.4700AID1845655
N-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)IC50 (µMol)50.00000.70000.70000.7000AID1625159
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)IC50 (µMol)82.00000.00020.606010.0000AID1845614
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)IC50 (µMol)9.40003.00006.20009.4000AID1845620
Transient receptor potential cation channel subfamily M member 8Rattus norvegicus (Norway rat)IC50 (µMol)0.21000.05802.65048.3000AID1349257
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)IC50 (µMol)5.40000.01802.01349.9000AID1845623
Diacylglycerol lipase-alphaHomo sapiens (human)IC50 (µMol)50.00000.00101.05385.0119AID1625150
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)IC50 (µMol)15.70000.80002.93336.5000AID1845617
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel, subfamily V, member 3Rattus norvegicus (Norway rat)EC50 (µMol)5.30005.30005.30005.3000AID1349262
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)0.18000.00033.166210.0000AID1845625
Glutamate receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)0.31620.00411.89638.7000AID257800
Glutamate receptor 2Rattus norvegicus (Norway rat)EC50 (µMol)0.31620.00411.62517.6000AID257800
Glutamate receptor 3Rattus norvegicus (Norway rat)EC50 (µMol)0.31620.00411.17063.5000AID257800
Glutamate receptor 4Rattus norvegicus (Norway rat)EC50 (µMol)0.31620.00411.13393.5000AID257800
Cannabinoid receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)0.18540.00020.19211.9953AID257800; AID49474
Cannabinoid receptor 1Homo sapiens (human)EC50 (µMol)0.07500.00010.12752.2400AID1349254
Cannabinoid receptor 2 Homo sapiens (human)EC50 (µMol)0.16710.00030.15173.2800AID1349255; AID49690
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)EC50 (µMol)25.00000.00000.992210.0000AID1657599
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)EC50 (µMol)0.18000.06002.22238.4000AID1349256
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)6.20000.00051.06746.3096AID1349263; AID1845612
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)EC50 (µMol)5.30001.00002.74005.3000AID1845618
Transient receptor potential cation channel subfamily V member 4Rattus norvegicus (Norway rat)EC50 (µMol)16.10000.03000.33150.9000AID1349261
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)EC50 (µMol)16.10000.04902.60986.4000AID1845621
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)EC50 (µMol)19.00000.03000.45071.7000AID1349260
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)EC50 (µMol)19.00001.70004.36677.3000AID1845615
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cannabinoid receptor 1Homo sapiens (human)Log Ki0.00250.00030.00190.0036AID49325
Cannabinoid receptor 2 Homo sapiens (human)Log Ki0.00200.00050.00200.0035AID49851
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (350)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2A6Homo sapiens (human)
steroid metabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin catabolic processCytochrome P450 2A6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2B6Homo sapiens (human)
steroid metabolic processCytochrome P450 2B6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2B6Homo sapiens (human)
cellular ketone metabolic processCytochrome P450 2B6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2B6Homo sapiens (human)
positive regulation of acute inflammatory response to antigenic stimulusCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
spermatogenesisCannabinoid receptor 1Homo sapiens (human)
axonal fasciculationCannabinoid receptor 1Homo sapiens (human)
response to nutrientCannabinoid receptor 1Homo sapiens (human)
memoryCannabinoid receptor 1Homo sapiens (human)
positive regulation of neuron projection developmentCannabinoid receptor 1Homo sapiens (human)
negative regulation of serotonin secretionCannabinoid receptor 1Homo sapiens (human)
positive regulation of fever generationCannabinoid receptor 1Homo sapiens (human)
negative regulation of fatty acid beta-oxidationCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, GABAergicCannabinoid receptor 1Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 1Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 1Homo sapiens (human)
negative regulation of dopamine secretionCannabinoid receptor 1Homo sapiens (human)
response to nicotineCannabinoid receptor 1Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 1Homo sapiens (human)
response to cocaineCannabinoid receptor 1Homo sapiens (human)
glucose homeostasisCannabinoid receptor 1Homo sapiens (human)
positive regulation of apoptotic processCannabinoid receptor 1Homo sapiens (human)
response to ethanolCannabinoid receptor 1Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 1Homo sapiens (human)
negative regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
positive regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
regulation of insulin secretionCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicCannabinoid receptor 1Homo sapiens (human)
maternal process involved in female pregnancyCannabinoid receptor 1Homo sapiens (human)
regulation of feeding behaviorCannabinoid receptor 1Homo sapiens (human)
regulation of penile erectionCannabinoid receptor 1Homo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidCannabinoid receptor 1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationCannabinoid receptor 1Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 1Homo sapiens (human)
response to amphetamineCannabinoid receptor 2 Homo sapiens (human)
inflammatory responseCannabinoid receptor 2 Homo sapiens (human)
immune responseCannabinoid receptor 2 Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 2 Homo sapiens (human)
leukocyte chemotaxisCannabinoid receptor 2 Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicCannabinoid receptor 2 Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 2 Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 2 Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 2 Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 2 Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of cholesterol effluxPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
long-chain fatty acid transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of osteoblast differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of receptor signaling pathway via STATPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of low-density lipoprotein receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of MAP kinase activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adiponectin secretionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cardiac muscle hypertrophy in response to stressPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of connective tissue replacement involved in inflammatory response wound healingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
placenta developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
G protein-coupled receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of blood pressurePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of lipid storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of angiogenesisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
monocyte differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
epithelial cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to lipidPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
glucose homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
mRNA transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipoprotein transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of blood vessel endothelial cell migrationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
innate immune responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell fate commitmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
retinoic acid receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell maturationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
rhythmic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
white fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of SMAD protein signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cholesterol transporter activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to low-density lipoprotein particle stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of mitochondrial fissionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of extracellular matrix assemblyPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cellular response to transforming growth factor beta stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adipose tissue developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular associated smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular endothelial cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
fatty acid metabolic processCytochrome P450 2J2Homo sapiens (human)
icosanoid metabolic processCytochrome P450 2J2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2J2Homo sapiens (human)
regulation of heart contractionCytochrome P450 2J2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2J2Homo sapiens (human)
linoleic acid metabolic processCytochrome P450 2J2Homo sapiens (human)
organic acid metabolic processCytochrome P450 2J2Homo sapiens (human)
fatty acid metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
sphingosine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lipid catabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylphosphatidylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
negative regulation of hair cycleTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to hypoxiaTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell volume homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell-cell junction assemblyTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensory signaling pathwayTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to mechanical stimulusTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage chemotaxisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of neuron projection developmentTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin cytoskeleton organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
vasopressin secretionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of microtubule depolymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of interleukin-6 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to insulinTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
hyperosmotic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
glucose homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of vascular permeabilityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical microtubule organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of striated muscle contractionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of JNK cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule polymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of inflammatory responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
multicellular organismal-level water homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cartilage development involved in endochondral bone morphogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion importTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of monocyte chemotactic protein-1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage inflammatory protein 1 alpha productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-C motif) ligand 5 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
blood vessel endothelial cell delaminationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import into cytosolTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of brown fat cell differentiationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of aerobic respirationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
monoacylglycerol biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayDiacylglycerol lipase-alphaHomo sapiens (human)
neuroblast proliferationDiacylglycerol lipase-alphaHomo sapiens (human)
arachidonic acid metabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
diacylglycerol catabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidDiacylglycerol lipase-alphaHomo sapiens (human)
regulation of neuroinflammatory responseDiacylglycerol lipase-alphaHomo sapiens (human)
cannabinoid biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
sensory perceptionTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of axon extensionTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (111)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
iron ion bindingCytochrome P450 2A6Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A6Homo sapiens (human)
enzyme bindingCytochrome P450 2A6Homo sapiens (human)
heme bindingCytochrome P450 2A6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A6Homo sapiens (human)
monooxygenase activityCytochrome P450 2B6Homo sapiens (human)
iron ion bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-alpha-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
heme bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-beta-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2B6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2B6Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 1Homo sapiens (human)
identical protein bindingCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 2 Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 2 Homo sapiens (human)
transcription cis-regulatory region bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
transcription coregulator bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
double-stranded DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
prostaglandin receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
enzyme bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peptide bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
identical protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear retinoid X receptor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
arachidonic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA binding domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
LBD domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
alpha-actinin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
R-SMAD bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
E-box bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
STAT family protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
monooxygenase activityCytochrome P450 2J2Homo sapiens (human)
iron ion bindingCytochrome P450 2J2Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
isomerase activityCytochrome P450 2J2Homo sapiens (human)
linoleic acid epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
hydroperoxy icosatetraenoate isomerase activityCytochrome P450 2J2Homo sapiens (human)
arachidonic acid 5,6-epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
heme bindingCytochrome P450 2J2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2J2Homo sapiens (human)
hydrolase activity, acting on carbon-nitrogen (but not peptide) bondsN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylsphingosine amidohydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
fatty acid amide hydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-(long-chain-acyl)ethanolamine deacylase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
ceramidase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
DNA-binding transcription factor bindingN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
actin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensor activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase C bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lipid bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
stretch-activated, monoatomic cation-selective, calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
SH2 domain bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
alpha-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
beta-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein bindingDiacylglycerol lipase-alphaHomo sapiens (human)
metal ion bindingDiacylglycerol lipase-alphaHomo sapiens (human)
acylglycerol lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
lipoprotein lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
monoatomic ion transmembrane transporter activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (67)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2A6Homo sapiens (human)
cytoplasmic microtubuleCytochrome P450 2A6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A6Homo sapiens (human)
cytoplasmCytochrome P450 2A6Homo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneCytochrome P450 2B6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2B6Homo sapiens (human)
cytoplasmCytochrome P450 2B6Homo sapiens (human)
mitochondrial outer membraneCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
actin cytoskeletonCannabinoid receptor 1Homo sapiens (human)
growth coneCannabinoid receptor 1Homo sapiens (human)
presynaptic membraneCannabinoid receptor 1Homo sapiens (human)
membrane raftCannabinoid receptor 1Homo sapiens (human)
glutamatergic synapseCannabinoid receptor 1Homo sapiens (human)
GABA-ergic synapseCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
cytoplasmCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
dendriteCannabinoid receptor 2 Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneCannabinoid receptor 2 Homo sapiens (human)
perikaryonCannabinoid receptor 2 Homo sapiens (human)
endoplasmic reticulumCannabinoid receptor 2 Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
cytoplasmCannabinoid receptor 2 Homo sapiens (human)
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cytosolPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
intracellular membrane-bounded organellePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II transcription regulator complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
receptor complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2J2Homo sapiens (human)
extracellular exosomeCytochrome P450 2J2Homo sapiens (human)
cytoplasmCytochrome P450 2J2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2J2Homo sapiens (human)
cytoplasmN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
membraneN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomal lumenN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
extracellular exosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cytoplasmTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
lysosomeTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
receptor complexTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
cytoplasmic microtubuleTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
endoplasmic reticulumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
adherens junctionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
focal adhesionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
apical plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lamellipodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
filopodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
growth coneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical actin cytoskeletonTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ruffle membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneDiacylglycerol lipase-alphaHomo sapiens (human)
early endosome membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendritic spine membraneDiacylglycerol lipase-alphaHomo sapiens (human)
varicosityDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic density membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
cytoplasmDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic membraneDiacylglycerol lipase-alphaHomo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
growth cone membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
melanosomeTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
axonal growth coneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
cell bodyTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (105)

Assay IDTitleYearJournalArticle
AID1845649Binding affinity to CB1 (unknown origin) assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID167510Number of rabbits convulsed at 15 mg/kg, iv out of 10 rabbits tested1982Journal of medicinal chemistry, May, Volume: 25, Issue:5
Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.
AID1625153Inhibition of MAGL in African green monkey COS cell homogenates using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID362544Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1845619Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID362541Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1845655Non competitive inhibition of CYP2J2 (unknown origin) in presence of NADPH by LC-MS/MS analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID49838Binding affinity of compound towards Cannabinoid receptor 2 in african green monkey COS-7 cells transfected with cDNA of human CB2 receptor1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
AID1845612Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625146Displacement of [3H]-CP55940 from recombinant human CB1 receptor expressed in Sf9 cell membranes co-expressing Galphai3beta1gamma2 measured after 90 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845628Agonist activity at TRPA1 (unknown origin) channel desensitization in presence of icilin2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625160Inhibition of recombinant human NAAA expressed in HEK293 cells at 100 uM using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1782665Inhibition of human LDHB assessed as reduction in lactate production using pyruvate as substrate at 10 uM in presence of NADH by spectrophotometric analysis relative to control2021Journal of natural products, 05-28, Volume: 84, Issue:5
Cannabichromene and Δ
AID362546Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1349259Activation of recombinant full length human CB2 receptor expressed in HEK293 cell membranes at 10 uM after 90 mins by topcount scintillation counting analysis relative to control2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1524901Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845618Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845613Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID362542Antibacterial activity against macrolide-resistant Staphylococcus aureus RN4220 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1845650Binding affinity to to CB1 (unknown origin) expressed in CHO -k1 cells assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845659Inhibition of recombinant human CYP2B6 using coumarin as substrate preincubated with NADPH for 20 mins and measured after 30 min by Lineweaver-burk plots analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625163Inhibition of [14C]-AEA uptake in rat RBL2H3 cells at 25 uM by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1524906Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID49315Binding affinity was determined for Cannabinoid receptor 12000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.
AID1133174Antihemolytic potency against hypotonic lysis-induced erythrocytes (unknown origin) assessed as stabilization1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.
AID1845616Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID167508Number of rabbits convulsed at 10 mg/kg, iv out of 6 rabbits tested1982Journal of medicinal chemistry, May, Volume: 25, Issue:5
Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.
AID1524905Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845615Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625157Inhibition of FAAH in rat brain membranes at 50 uM using [14C]-AEA as substrate measured after 30 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1349258Activation of recombinant full length human CB1 receptor expressed in HEK293 cell membranes at 10 uM after 90 mins by topcount scintillation counting analysis relative to control2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1845653Neuroprotection against glutamate-induced oxytosis in mouse HT-22 cells assessed as cell viability2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845623Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) channel desensitization in presence of 4alphaPDD2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524910Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID362545Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID49474Effective concentration for inhibition of Cannabinoid receptor 1-mediated adenylyl cyclase activity using African green monkey (COS-7) cells transfected with the cDNA of rat CB1 receptor1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
AID1524908Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845658Mixed inhibition of recombinant human CYP2B6 using coumarin as substrate preincubated with NADPH for 20 mins and measured after 30 min by Lineweaver-burk plots analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1453018Competitive inhibition of human liver microsomes CYP1A1 expressed in supersomes coexpressing NADPH-CYP reductase using 7-Ethoxyresorufin as substrate measured every 5 mins for 30 mins in presence of NADPH by fluorescence assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1524903Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524914Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845648Displacement of 35S]GTPgammaS from human CB2 receptor transfected in CHO cells assessed as inhibition forskolin-stimulated cyclic AMP production2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID49851Binding affinity towards cloned human cannabinoid receptor 22000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
AID1625150Inhibition of recombinant human DAGLalpha expressed in COS7 cells using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID362543Antibacterial activity against tetracycline-resistant Staphylococcus aureus XU212 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID49325Binding affinity towards cloned human Cannabinoid receptor 12000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
AID1845617Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) channel desensitization in presence of lysophosphatidylcholine2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845657Non competitive inhibition of recombinant human CYP2A6 using coumarin as substrate preincubated with NADPH for 20 mins and measured after 30 min by Lineweaver-burk plots analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845614Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) channel desensitization in presence of capsaicin2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845622Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625156Inhibition of FAAH in rat brain membranes using [14C]-AEA as substrate measured after 30 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625151Inhibition of recombinant human DAGLalpha expressed in COS7 cells at 50 uM using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625155Inhibition of MAGL in African green monkey COS cell homogenates at 50 uM using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID227699Virtual screen for compounds with anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
AID257800Displacement of [35S]GTP-gamma-S from rat cerebellar CB1 receptor2006Journal of medicinal chemistry, Jan-26, Volume: 49, Issue:2
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
AID1657599Agonist activity at GAL4-tagged PPARgamma (unknown origin) transiently expressed in HEK293T cells co-transfected with GAL4-tagged luc incubated for 6 hrs by dual luciferase reporter gene assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
The Oxidation of Phytocannabinoids to Cannabinoquinoids.
AID1845654Antibacterial activity against methicillin-resistant Staphylococcus aureus2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID49496Binding affinity of compound towards Cannabinoid receptor 1 in rat brain synaptosomal membrane preparations1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
AID1349261Agonist activity at recombinant rat TRPV4 expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo4-AM probe based fluorescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1524907Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID49690Effective concentration for inhibition of human Cannabinoid receptor 2-mediated adenylyl cyclase using African green monkey (COS-7) cells transfected with the cDNA of human CB2 receptor1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
AID1524911Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524912Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845651Binding affinity to to CB2 receptor (unknown origin) expressed in CHO -k1 cells assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1349255Displacement of 3H-CP-55940 from recombinant full length human CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount scintillation counting analysis2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1845627Agonist activity at TRPA1 (unknown origin) channel desensitization in presence of isothiocyanate2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524909Cytotoxicity against human OVCAR cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1133173Inhibition of mouse brain synaptosomal Lysophosphatidylcholine acyltransferase using substrate [32P]lysophosphatidylcholine and oleoyl-CoA1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.
AID165405Capability to induce convulsions in tetrahydrocannabinol-seizure susceptible (THC-SS) rabbit1982Journal of medicinal chemistry, May, Volume: 25, Issue:5
Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.
AID1349262Agonist activity at recombinant rat TRPV3 expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo4-AM probe based fluorescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID49846Binding affinity was determined for Cannabinoid receptor 22000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.
AID1524913Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1453019Competitive inhibition of human liver microsomes CYP1A2 expressed in supersomes coexpressing NADPH-CYP reductase using 7-Ethoxyresorufin as substrate measured every 5 mins for 30 mins in presence of NADPH by fluorescence assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1349260Agonist activity at recombinant rat TRPV2 expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo4-AM probe based fluorescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1349254Displacement of 3H-CP-55940 from recombinant full length human CB1 receptor expressed in HEK293 cell membranes after 90 mins by topcount scintillation counting analysis2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1625159Inhibition of recombinant human NAAA expressed in HEK293 cells using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845656Non competitive inhibition of recombinant human CYP2A6 using coumarin as substrate preincubated with NADPH for 20 mins and measured after 30 min2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID243998Inhibitory potency against fatty acid amide hydrolase activity in mouse brain microsomes in presence of 58 uM anandamide at 160 uM2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
AID49495Binding affinity of compound towards Cannabinoid receptor 1 in african green monkey COS-7 cells transfected with cDNA of rat CB1 receptor1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
AID1524904Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524902Cytotoxicity against human OVCAR cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845626Agonist activity at TRPA1 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1349263Agonist activity at human TRPV1 expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo4-AM probe based fluorescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1349257Antagonist activity at recombinant rat TRPM8 expressed in HEK293 cells assessed as inhibition of icilin-induced intracellular calcium level incubated for 5 mins followed by agonist stimulation by Fluo4-AM probe based fluorescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1349256Agonist activity at recombinant rat TRPA1 expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo4-AM probe based fluorescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
AID1845621Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625147Displacement of [3H]-CP55940 from recombinant human CB2 receptor expressed in Sf9 cell membranes co-expressing Galphai3beta1gamma2 measured after 90 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845625Agonist activity at TRPA1 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524917Inhibition of Wnt/beta-catenin signaling pathway in human HepG2 cells assessed as reduction in TCF-dependent beta-catenin mediated transcription at 5 to 40 uM incubated for 24 hrs by Topflash reporter assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845620Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) channel desensitization in presence of carvacrol2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845652Binding affinity to to CB2 receptor (unknown origin) expressed in AtT20 cells assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1133175Molar volume, Vm of the compound at zero temperature1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.
AID1625162Inhibition of [14C]-AEA uptake in rat RBL2H3 cells by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1453020Competitive inhibition of human liver microsomes CYP1B1 expressed in supersomes coexpressing NADPH-CYP reductase using 7-Ethoxyresorufin as substrate measured every 5 mins for 30 mins in presence of NADPH by fluorescence assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1346701Human CB1 receptor (Cannabinoid receptors)1995Molecular pharmacology, Sep, Volume: 48, Issue:3
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
AID1346701Human CB1 receptor (Cannabinoid receptors)1996The Journal of pharmacology and experimental therapeutics, Sep, Volume: 278, Issue:3
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
AID1346564Rat TRPV2 (Transient Receptor Potential channels)2008The Journal of neuroscience : the official journal of the Society for Neuroscience, Jun-11, Volume: 28, Issue:24
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID493017Wombat Data for BeliefDocking2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (297)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990102 (34.34)18.7374
1990's25 (8.42)18.2507
2000's36 (12.12)29.6817
2010's66 (22.22)24.3611
2020's68 (22.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.61 (24.57)
Research Supply Index5.79 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index103.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (60.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (3.17%)5.53%
Reviews20 (6.35%)6.00%
Case Studies1 (0.32%)4.05%
Observational0 (0.00%)0.25%
Other284 (90.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]